- Home
- DNLI vs CCB Comparison
DNLI vs CCB Comparison
Compare DNLI & CCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- CCB
- Stock Information
- Founded
- DNLI 2013
- CCB 1997
- Country
- DNLI United States
- CCB United States
- Employees
- DNLI N/A
- CCB N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- CCB Major Banks
- Sector
- DNLI Health Care
- CCB Finance
- Exchange
- DNLI Nasdaq
- CCB Nasdaq
- Market Cap
- DNLI 2.1B
- CCB 1.7B
- IPO Year
- DNLI 2017
- CCB 2018
- Fundamental
- Price
- DNLI $14.19
- CCB $109.10
- Analyst Decision
- DNLI Strong Buy
- CCB Strong Buy
- Analyst Count
- DNLI 16
- CCB 3
- Target Price
- DNLI $33.62
- CCB $105.00
- AVG Volume (30 Days)
- DNLI 2.0M
- CCB 110.9K
- Earning Date
- DNLI 11-05-2025
- CCB 10-27-2025
- Dividend Yield
- DNLI N/A
- CCB N/A
- EPS Growth
- DNLI N/A
- CCB 18.14
- EPS
- DNLI N/A
- CCB 3.25
- Revenue
- DNLI N/A
- CCB $336,394,000.00
- Revenue This Year
- DNLI N/A
- CCB $83.27
- Revenue Next Year
- DNLI $802.87
- CCB $35.03
- P/E Ratio
- DNLI N/A
- CCB $33.57
- Revenue Growth
- DNLI N/A
- CCB 28.83
- 52 Week Low
- DNLI $10.57
- CCB $48.52
- 52 Week High
- DNLI $33.33
- CCB $118.00
- Technical
- Relative Strength Index (RSI)
- DNLI 41.95
- CCB 51.22
- Support Level
- DNLI $14.63
- CCB $109.73
- Resistance Level
- DNLI $15.69
- CCB $112.45
- Average True Range (ATR)
- DNLI 0.68
- CCB 3.09
- MACD
- DNLI -0.14
- CCB -0.77
- Stochastic Oscillator
- DNLI 0.99
- CCB 0.78
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About CCB Coastal Financial Corporation
Coastal Financial Corp is a bank holding company. Through its subsidiaries, the company conducts its business in three reportable segments which include, Community Bank, CCBX, and Treasury and Administration. The Community Bank segment includes all community banking activities, with a primary focus on providing various banking products and services to consumers and small to medium-sized businesses. The CCBX segment provides Banking as a Service (BaaS) that allows its broker dealers and digital financial service partners to offer their customers banking services, and the Treasury and administration segment includes treasury management, overall administration, and all other aspects of the company. The maximum revenue of the company is generated from the CCBX segment.